The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
2015 · Oncogenesis · 100 citations
https://doi.org/10.1038/oncsis.2015.16
A
Akimitsu Yamada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
332
Papers
4.1K
Citations
30
h-index
72
i10-index
Akimitsu Yamada is an academic researcher from Yokohama City University Medical Center. The author has contributed to research in topics: Sphingolipid Metabolism and Signaling & Breast Cancer Treatment Studies & Breast Lesions and Carcinomas. The author has an h-index of 30, co-authored 283 publications.
ORCID: 0000-0003-3006-0648Papers by this author
worksSphingosine-1-phosphate in the lymphatic fluid determined by novel methods
2016 · Heliyon · 39 citations
https://doi.org/10.1016/j.heliyon.2016.e00219
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan
2020 · Breast Cancer · 19 citations
https://doi.org/10.1007/s12282-020-01188-8
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study
2021 · Anticancer Research · 8 citations
https://doi.org/10.21873/anticanres.14863
Impacts and Predictors of Cytotoxic Anticancer Agents in Different Breast Cancer Subtypes
2012 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 6 citations
https://doi.org/10.3727/096504012x13473664562565
Breast cancer in adolescents and young adults has a specific biology and poor patient outcome compared with older patients
2024 · ESMO Open · 6 citations
https://doi.org/10.1016/j.esmoop.2024.103737
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat